Replimune Raises $55 Million to Advance its Oncolytic … – PR Newswire (press release)
Endpoints NewsReplimune Raises $55 Million to Advance its Oncolytic …PR Newswire (press release)Replimune Group Inc., a biotechnology company focused on developing next generation oncolytic immunotherapies, announced today the completion of a $55&nbs… Continue reading
